Arteriovenous Fistula

Hemodiafiltration may be associated with better cardiovascular and overall survival vs. high-flux hemodialysis for patients on dialysis, according to a European Renal Association consensus statement.

Greater access to community health centers may improve outcomes for Medicaid recipients and adults without insurance who have end-stage kidney disease, data show. Amid systematic barriers in health care, “nephrology is unique in that U.S. federal health insurance, Medicare, covers most patients with ESKD irrespective of age or income,” Yoshio N. Hall, MD, MS, academic professor of medicine in nephrology at the University of Washington Kidney Research Institute in Seattle, told Healio. “However, this near-universal coverage does not extend to patients with non-dialysis-dependent kidney disease. As such, most nephrology practices in the U.S. continue to focus their care on patients who require maintenance dialysis."

SAN DIEGO — Nearly one-third of disparities in vascular access outcomes for Hispanic vs. non-Hispanic white patients with end-stage kidney disease can be tied to pre-dialysis care inequities, data show.

East Side Vascular Access (East Side) is a member of St. Clair Nephrology, a specialty medical practice with offices across the greater Metro-Detroit area. At East Side, the access center has an average of five patient encounters per day and about 1,100 encounters each year. St Clair Nephrology physicians are medical directors at multiple dialysis centers. Our role within the network is to provide access-related services to the patients who are referred by all the dialysis centers in our area.

Adults with pregnancy-related end-stage kidney disease have reduced access to transplant and nephrology care, which may worsen racial gaps for Black patients with this condition, according to a study.

Although the rate of complications for hospitalized patients with end-stage kidney disease on dialysis declined between 2005 and 2018, patients from underrepresented groups showed higher odds of complications compared with white patients.

Nephrologists have several options when it comes to new vascular access devices and technologies, according to a presentation at the Innovations in Dialysis: Expediting Advances Symposium.

CMS has released a proposed rule for the 2023 Physician Fee Schedule with some mix results for nephrologists, according to the Renal Physician Association.

The FDA granted breakthrough device designation to First Assist Devices LLC for its First Assist Model FA-1 device, according to a press release.

Teleflex announced a worldwide recall of its percutaneous thrombolytic device for mechanical declotting of native arteriovenous fistulae and synthetic dialysis grafts.